November 01, 2021 / 18:07 IST
Reported Standalone quarterly numbers for Bharat Immunologicals and Biologicals Corporation are:Net Sales at Rs 24.70 crore in September 2021 down 2.59% from Rs. 25.36 crore in September 2020.
Story continues below Advertisement
Quarterly Net Loss at Rs. 9.36 crore in September 2021 down 142.12% from Rs. 3.87 crore in September 2020.
EBITDA stands negative at Rs. 3.27 crore in September 2021 up 25% from Rs. 4.36 crore in September 2020.
Bharat Immuno shares closed at 54.10 on October 29, 2021 (BSE) and has given 14.74% returns over the last 6 months and 114.26% over the last 12 months.
| Bharat Immunologicals and Biologicals Corporation | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'21 | Jun'21 | Jun'20 | | Net Sales/Income from operations | 24.70 | 14.22 | 19.15 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 24.70 | 14.22 | 19.15 | | EXPENDITURE | | Consumption of Raw Materials | 14.20 | 20.64 | 21.41 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 7.76 | -11.79 | -7.61 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.05 | 2.83 | 1.58 | | Depreciation | 0.06 | 0.06 | 0.06 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 3.18 | 1.49 | 3.13 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -3.55 | 0.98 | 0.57 | | Other Income | 0.22 | 0.25 | -0.58 | | P/L Before Int., Excpt. Items & Tax | -3.33 | 1.23 | -0.01 | | Interest | 1.23 | 1.16 | 1.09 | | P/L Before Exceptional Items & Tax | -4.56 | 0.07 | -1.10 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -4.56 | 0.07 | -1.10 | | Tax | 4.80 | -1.85 | -0.32 | | P/L After Tax from Ordinary Activities | -9.36 | 1.93 | -0.78 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -9.36 | 1.93 | -0.78 | | Equity Share Capital | 43.18 | 43.18 | 43.18 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.17 | 0.45 | -0.18 | | Diluted EPS | -2.17 | 0.45 | -0.18 | | EPS After Extra Ordinary | | Basic EPS | -2.17 | 0.45 | -0.18 | | Diluted EPS | -2.17 | 0.45 | -0.18 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
